TrialThe Journal of clinical investigation2020

Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis.

Panagiotis Skendros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.